RT Journal Article
SR Electronic
T1 Sustainable Development Goals and Health Sector Strategic Indicators Assessment in Cameroon: A Retrospective Analysis at Regional and National Levels
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.11.25.24317921
DO 10.1101/2024.11.25.24317921
A1 Cheuyem, Fabrice Zobel Lekeumo
A1 Ajong, Brian Ngongheh
A1 Amani, Adidja
A1 Boukeng, Lionel Berthold Keubou
A1 Ngos, Christelle Sandrine
A1 Nkongo, Florence Kissougle
A1 Tsafack, Martine Golda Mekouzou
A1 Mvondo, Esther Andriane Bitye Bi
A1 Nloga, Guy Stephane
A1 Nouko, Ariane
A1 Edzamba, Michel Franck
A1 Nyonga, Denetria Ngati
A1 Fouda, Fernande Murielle Mba
A1 Kam, Yollande Ngo
A1 Mouangue, Christian
YR 2024
UL http://medrxiv.org/content/early/2024/11/28/2024.11.25.24317921.abstract
AB Background Cameroon has developed a Health Sector Strategy (HSS) that aims at fostering a healthy and productive human capital. To achieve this objective, key health indicators have been defined to track progress towards the goal. This study was conducted to provide evidence on the current situation and assess progress towards achieving the HSS and other key health indicators in the Centre Region and in Cameroon.Methods Data were collected in April 2023 through a through a comprehensive review of online documents and databases. They were collected retrospectively till 2022. Data were retrieved from the national database using DHIS2 version 2.40 and checked for completeness. Additional data were gathered from online surveys and reports available including Demographic and Health Survey, Multiple Indicators Cluster Survey, National Statistical Institute report for the Centre Region.Results At national level, the highest performance was observed in the proportion of HIV-positive pregnant women receiving ART (99%), while the lowest performance was observed in the reduction of the prevalence of chronic malnutrition among children under five, with 63% of the target achieved. In the Centre Region, the national target of reducing the prevalence of chronic malnutrition to 11% was achieved. The lowest performance was observed in the proportion of children under five sleeping under long-lasting insecticidal nets. The density of health facilities was above target at national level (2.3 per 10,000 population) but below target at regional level (1.4 per 10,000 population). Coverage of tracer antigens (Penta 3, BCG) decreased over the five-year study period, falling below the national target of 95% in 2022. However, coverage remained above the national average throughout the study period. Coverage of pregnant women attending four or more antenatal clinics and receiving at least three doses of intermittent preventive treatment (IPT) remained low from 2018 to 2022.Conclusions Significant progress has been made in strengthening the healthcare system and fostering a healthy, productive workforce. Nevertheless, further efforts are required to prevent malaria transmission, promote antenatal care utilization among pregnant women, and address nutritional insecurity in certain Regions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of the Faculty of Medicine of Yaounde waived ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscriptBCGBacillus Calmet GuerinCOVID-19New Coronavirus DiseaseHIVHuman Immunodeficiency VirusHSSHealth Sector StrategyDHISDistrict Health Information SoftwareAIDSAcquired Immunodeficiency SyndromeARTAntiretroviral TherapyPentaPentavalent VaccineSDGSustainable Development GoalLLINLong-Lasting Insecticidal NetIPTIntermittent Preventive Treatment